Significant Ownership of Avidity Partners Management LP

Signature - Title
By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory - Michael Gregory / Managing Member
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avidity Partners Management LP.

Notify me when Avidity Partners Management LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Avidity Partners Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 9.9% $8,913,522 +$72,083 9,200,580 +0.82% Avidity Partners Management LP 30 Sep 2025
SCYX Scynexis, Inc. Common Stock, par value $0.001 per share 9.9% $3,477,903 +$234,763 4,516,757 +7.2% Avidity Private Master Fund I LP 30 Sep 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 7.6% $61,441 2,048,020 Avidity Partners Management LP 31 Dec 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 6.9% $397,054 502,600 Avidity Partners Management LP 31 Dec 2024
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value 4.9% $70,995,168 -$43,010,234 2,104,184 -38% Avidity Partners Management LP 17 Nov 2025
IMUX Immunic, Inc. Common Stock, $0.0001 par value 4.8% $4,143,001 -$807,898 4,699,411 -16% Avidity Partners Management LP 30 Sep 2025
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 4.2% $6,903,688 2,841,024 Avidity Partners Management LP 31 Dec 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 0% $0 0 Avidity Partners Management LP 30 Sep 2025

Schedules 13D/G Reported by Avidity Partners Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.